Spasmodic Dysphonia Clinical Trial
Official title:
Brain Networks in Dystonia
Task-specific focal dystonias are characterized by selective activation of dystonic movements during performance of highly learned motor tasks, such as writing or playing a musical instrument. To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of task-specificity in focal dystonias, which affect similar muscle groups but result in different clinical manifestations, such as writer's cramp vs. pianist's dystonia or spasmodic dysphonia vs. singer's dystonia. Our goal is to dissect the pathophysiological mechanisms underlying the phenomenon of task specificity in isolated focal dystonias using multi-level brain network analysis in conjunction with neuropathological examination of postmortem brain tissue from patients with dystonia. Rather than viewing these disorders as interesting curiosities, understanding the biology of task-specific activation of motor programs is central to understanding dystonia.
Task-specific primary focal dystonias (tsPFDs) are characterized by selective activation of dystonic movements during performance of highly learned motor tasks, such as writing, playing a musical instrument, speaking, or singing. Despite the recent advances in describing the clinical features of dystonia, there is a fundamental gap in understanding the neural abnormalities underlying the development of tsPFDs, which affect the same muscles but result in different clinical manifestations as in writer's cramp vs. pianist's dystonia or spasmodic dysphonia vs. singer's dystonia. Continued existence of this gap is an important problem because it renders us unable to differentiate between primary and secondary brain changes contributing to the tsPFD pathophysiology and to develop novel treatment options targeting disorder-specific brain alterations. The objective of this application is to identify the brain mechanisms underlying the phenomenon of task specificity in two representative groups of patients with writer's cramp vs. musician's hand dystonia and spasmodic dysphonia vs. singer's laryngeal dystonia using a novel approach of combined clinico-behavioral examination, brain network analysis and quantitative neuropathology of postmortem brain tissue. Our central hypothesis is that each tsPFD is characterized by distinct brain abnormalities, which selectively affect the focal segments of brain networks responsible for the performance of the respective motor task. The rationale for the proposed research is that identification of tsPFD-specific brain changes and associated neuropathology will clarify the neural mechanisms (primary vs. secondary) contributing to the clinical manifestation of these disorders and thus explain the phenomenon of tsPFDs. The obtained results are expected to provide strong scientific bases for the next series of studies directed towards identification and validation of novel pharmacological and/or surgical therapies for these patients. The researchers will pursue the following two specific aims: (1) determine distinct features of brain functional network abnormalities underlying task-specificity in different tsPFDs, and (2) establish structural correlates of functional neuroimaging abnormalities in tsPFDs. The proposed research is significant because it is expected to establish scientific evidence that tsPFD is a network disorder with abnormalities following distinct patterns in different tsPFDs and certain abnormalities showing structure-function correlations are associated with underlying neuropathology. By converging the results from multimodal cross-disciplinary studies to a coherent and pathophysiologically meaningful picture, the researchers will be well positioned to identify primary vs. secondary changes in tsPFDs and establish a scientific framework for the development of diagnostic biomarkers and novel treatment options for these disorders. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06111027 -
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02061943 -
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
|
N/A | |
Recruiting |
NCT05158166 -
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Recruiting |
NCT05580302 -
Cortical Silent Period in Laryngeal Dystonia
|
||
Recruiting |
NCT05150106 -
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
|
||
Recruiting |
NCT05216770 -
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
|
Early Phase 1 | |
Recruiting |
NCT05150093 -
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
|
N/A | |
Completed |
NCT00713414 -
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
|
||
Completed |
NCT01961297 -
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
|
Phase 2 | |
Completed |
NCT00118586 -
Neuropathology of Spasmodic Dysphonia
|
||
Not yet recruiting |
NCT04938154 -
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
|
Phase 2 | |
Active, not recruiting |
NCT03292458 -
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
|
Phase 2/Phase 3 | |
Completed |
NCT02957942 -
rTMS in Spasmodic Dysphonia
|
N/A | |
Completed |
NCT02558634 -
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial
|
N/A | |
Terminated |
NCT00895063 -
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
|
N/A | |
Completed |
NCT05158179 -
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
|
N/A | |
Not yet recruiting |
NCT06078527 -
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
|
N/A | |
Enrolling by invitation |
NCT05892770 -
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Completed |
NCT04648891 -
Spasmodic Dysphonia Pain
|
Phase 2/Phase 3 | |
Completed |
NCT03746509 -
Laryngeal Vibration for Spasmodic Dysphonia
|
N/A |